A previous study demonstrated that high ASF1B expression is highly correlated with prostate cancer (PCa) lymph node metastasis (TNM) staging and that silencing ASF1B inhibits the PI3K/Akt signaling pathway, thereby suppressing PCa cell proliferation and promoting apoptosis and cell cycle arrest.8 This evidence concerns the gene ASF1B and prostate carcinoma.